Bath & Body Works (NYSE:BBWI – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 1.940-2.070 for the period, compared to the consensus estimate of 1.970. The company issued revenue guidance of $2.7 billion-$2.8 billion, compared to the consensus revenue estimate of $2.7 billion. Bath & Body Works also updated its Q4 guidance to $1.94-2.07 EPS.
Bath & Body Works Trading Up 2.0 %
BBWI stock opened at $35.92 on Thursday. The stock’s 50 day simple moving average is $30.81 and its 200 day simple moving average is $35.65. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a market capitalization of $7.87 billion, a PE ratio of 8.76, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. On average, research analysts predict that Bath & Body Works will post 3.18 earnings per share for the current year.
Bath & Body Works Announces Dividend
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on BBWI shares. Robert W. Baird decreased their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Barclays boosted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday. Raymond James dropped their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a research report on Monday. Finally, UBS Group dropped their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $41.88.
Check Out Our Latest Analysis on Bath & Body Works
Insider Buying and Selling at Bath & Body Works
In other news, CEO Gina Boswell bought 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were bought at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.27% of the company’s stock.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
See Also
- Five stocks we like better than Bath & Body Works
- How Technical Indicators Can Help You Find Oversold StocksĀ
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Investors Need to Know About Upcoming IPOs
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.